Global Pharmaceutical Grade Dicalcium Phosphate Dihydrate Market Growth 2025-2031

The global Pharmaceutical Grade Dicalcium Phosphate Dihydrate market size is predicted to grow from US$ 127 million in 2025 to US$ 162 million in 2031; it is expected to grow at a CAGR of 4.1% from 2025 to 2031.

Dicalcium phosphate dihydrate (chemical formula: CaHPO ₄ · 2H ₂ O) is a calcium phosphate compound containing hydrated molecules, commonly known as calcium hydrogen phosphate dihydrate. It is an important derivative of calcium phosphate, widely used in biomedical, agricultural, and industrial fields. In the pharmaceutical industry, dicalcium phosphate dihydrate is often used as a filler for tablets and capsules, which helps in the formation of drugs. Compared to some other fillers, it has better fluidity and compressibility, which can help drugs form better during the compression process and ensure the quality of tablets. Calcium hydrogen phosphate tablets can supplement the calcium element needed by the human body, mainly used to treat symptoms such as fatigue and osteoporosis caused by calcium deficiency. In severe cases, they can even have therapeutic effects on conditions such as rickets and fractures. The applicable population mainly includes pregnant women, lactating women, and children, but it needs to be used under the guidance of a doctor.

United States market for Pharmaceutical Grade Dicalcium Phosphate Dihydrate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Pharmaceutical Grade Dicalcium Phosphate Dihydrate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Pharmaceutical Grade Dicalcium Phosphate Dihydrate is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Pharmaceutical Grade Dicalcium Phosphate Dihydrate players cover ICL, Aarti Industries, Prayon, JRS PHARMA, Innophos, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Grade Dicalcium Phosphate Dihydrate Industry Forecast” looks at past sales and reviews total world Pharmaceutical Grade Dicalcium Phosphate Dihydrate sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade Dicalcium Phosphate Dihydrate sales for 2025 through 2031. With Pharmaceutical Grade Dicalcium Phosphate Dihydrate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade Dicalcium Phosphate Dihydrate industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade Dicalcium Phosphate Dihydrate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade Dicalcium Phosphate Dihydrate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Grade Dicalcium Phosphate Dihydrate market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade Dicalcium Phosphate Dihydrate and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade Dicalcium Phosphate Dihydrate.

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Dicalcium Phosphate Dihydrate market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Powder
Granules

Segmentation by Application:
Pharmaceutical Fillers
Calcium Supplements

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
ICL
Aarti Industries
Prayon
JRS PHARMA
Innophos
SBF Pharma
Huzhou Zhanwang Pharmaceutical
Huzhou City Linghu Xinwang Chemical
Anhui Sunhere Pharmaceutical Excipients
Guangdong Guanghua Sci-Tech
Luoyang Longmen Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharmaceutical Grade Dicalcium Phosphate Dihydrate market?

What factors are driving Pharmaceutical Grade Dicalcium Phosphate Dihydrate market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharmaceutical Grade Dicalcium Phosphate Dihydrate market opportunities vary by end market size?

How does Pharmaceutical Grade Dicalcium Phosphate Dihydrate break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.